Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699386 · ClinicalTrials.gov registry record · Phase 3
Growth of Infants Fed an Elemental Medical Food
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 213
- Enrollment target
NCT01699386: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01699386 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 213 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01699386, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 213 participants
- Enrollment target
Study Summary
Effects on weight will be monitored in healthy infant subjects consuming assigned infant formulas.
Primary Outcome
weight gain during the study period
Interventions
- OTHER Control Study Formula
- OTHER Experimental Study Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 1999-04 |
| Est. Completion | 2000-12 |
| Phase | Phase 3 |
What the finished NCT01699386 record still lists
NCT01699386 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Study Formula is the first listed.
NCT01699386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01699386 about?
NCT01699386 is a clinical study titled "Growth of Infants Fed an Elemental Medical Food". Effects on weight will be monitored in healthy infant subjects consuming assigned infant formulas.
What is the current status of trial NCT01699386?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 213 participants. The study started on 1999-04. Estimated completion is 2000-12.
What interventions are being tested in trial NCT01699386?
The interventions under investigation include: Control Study Formula (OTHER), Experimental Study Formula (OTHER).
Who is sponsoring clinical trial NCT01699386?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01699386's enrollment target sits among peer trials
213 1335th of 2000 higher than 666 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia